-
Barb Maxwell, RN, MHA, COHN-S, CCM, CWCP, and her colleagues had braced themselves for the new survey process of the Joint Commission on Accreditation of Healthcare Organizations (JCAHO). They knew they had to be ready for the unexpected.
-
Red rules have earned Sentara Norfolk (VA) General Hospital a golden award. The hospital won the American Hospital Quest for Quality Prize from the American Hospital Association for creating an institutionwide cultural transformation with a commitment to safety. The prize: $75,000.
-
You cant manage workers compensation costs if you cant track those costs. That basic truth led OSF Saint Francis Medical Center in Peoria to rethink its system, beginning with the first report of a work-related injury.
-
CDC: Mismatched flu vaccine still effective
-
-
The Prostate Cancer Outcomes Study reports health-related quality-of-life findings 5 years after diagnosis on a cohort of prostate cancer patients who had either initial radical prostatectomy or external beam radiation therapy. Patients who were treated with radiation were more likely to experience rectal discomfort and hemorrhoidal pain, whereas those who were treated surgically suffered a somewhat greater rate of urinary incontinence.
-
Accurate staging is essential for providing appropriate therapy for small-cell lung cancer because patients with disease confined to one hemi-thorax (limited stage) are treated quite differently that those with more extensive disease at presentation. In the current report from a single institution, the value of pretreatment PET was determined. Of 24 patients considered by conventional imaging studies to have limited disease, two were correctly upstaged on the basis of the PET.
-
Routine pelvic and para-aortic lymph node dissection is not necessary in the majority of women with ovarian low malignant potential tumors.
-
-
YKL-40 may represent a novel marker for the detection of early stage ovarian cancer. YKL-40 levels in early stage patients may also predict disease recurrence and survival. The use of YKL-40 in detection of early stage ovarian cancer deserves further investigation.
